Residencies and Fellowships
GSK has a rich history of collaboration with leading US academic institutions through sponsorship of joint fellowship programs. Currently, our programs focus on drug development, clinical pharmacokinetics/pharmacodynamics, and drug/medical information. Most graduates of these programs have gone on to successful industry and/or academic careers.
We sponsor fellowship and residency opportunities with two major North Carolina universities: UNC-Chapel Hill and Duke. Core areas of study include:
- Drug Development (UNC; PharmD or PhD; 2 years)
- Clinical Pharmacokinetics/Pharmacodynamics (UNC; PharmD or PhD; 2 years)
- Drug/Medical Information (Duke; PharmD; 1 year)
These programs are best suited for individuals interested in drug development. Fellowships are two years long; the first year is based on developing a scientific foundation in the area of interest, followed by a second year of practical application at GSK.
The drug/medical information residency lasts one year. Fellows and residents will spend time at both the affiliated university and an associated GSK site in Research Triangle Park, NC.
Drug Development Fellowhip (PharmD or PhD)
This fellowship offers participants:
- Orientation to all aspects of the drug development process (e.g., pre-clinical and clinical development)
- Experience in developing, reviewing, and composing protocols, study reports and regulatory submissions
- Exposure to the selection, set-up, and monitoring of clinical sites participating in Phase I, II, III, IV and/or pharmacokinetic studies
- Author abstracts, posters, and manuscripts that result from preclinical, pharmacokinetic and/or clinical studies
The first year is spent at the UNC Eshelman School of Pharmacy. Training includes didactic and practical experience in drug development and clinical research.
The second year is spent at GSK, where fellows participate in active projects or in-depth research. Fellows develop expertise in one or more of the following areas: proposal development; regulatory affairs; clinical site monitoring; data analysis, including PK and PD studies in healthy subjects, patient populations, or relevant in vitro/pre-clinical models; drug assay methodologies; biostatistical analysis.
Fellows may participate in selected coursework in clinical research methods, clinical study design, biostatistics, advanced pharmacokinetics and pharmacodynamics, pharmacogenomics, data management, advanced therapeutics, drug metabolism and/or molecular biology.
Clinical Pharmacokinetics/Pharmacodynamics Fellowship (PharmD or PhD)
The goal of the program is to provide research experience that enables the fellow to gain expertise in drug development, quantitative pharmacology, translational research and/or pharmacometrics while preparing the fellow for a career in a related field in an industrial, academic or regulatory organization.
Fellows participate in clinical pharmacology, drug transport and metabolism studies with faculty at the UNC Eshelman School of Pharmacy during the first year. Each fellow will design, initiate, conduct and analyze various research projects as a part of the learning experience. Fellows enroll in advanced pharmacokinetics/pharmacodynamics and clinical research methods courses, and may attend additional courses, such as biostatistics, advanced therapeutics, drug metabolism and molecular biology.
Fellows spend their second year at GSK as members of a research team applying state-of-the-art quantitative methodologies to the development of compounds in our portfolio, such as population pharmacokinetic and pharmacodynamic analyses, exposure-response, disease progression modeling and clinical trial simulations. Fellows contribute to the design and analysis of first-time-in-human, proof-of-concept, drug-drug interaction or other clinical pharmacology studies.
Fellows use advanced techniques as they participate in modeling and simulation efforts for quantitative decision making.
This 12-month residency provides specialty drug information training in the GSK Medical Information Department at the Research Triangle Park, NC campus (7 months) with additional clinical and drug information experiences at Duke University Hospital (5 months).
We provide support for a variety of therapeutic areas, including: Anti-infective, Gastrointestinal, Vaccines, Neurosciences, HIV, Oncology, Respiratory, Critical Care, Metabolic, Cardiovascular, and Urology.
The resident is a member of a therapeutic team at GSK,participating in activities that mirror those of a scientist. Activities for the resident include written and oral communication with healthcare professionals, evidence-based literature evaluation, product-specific database management, review of promotional materials, sales representative training, managed care and Medicaid dossier development and provision of medical expertise and support to various other departments within the company.
The 943-bed Duke University Hospital is consistently rated as one of the top hospitals in the US. Residents participate in clinical training and hospital-based drug information experiences at Duke University Hospital’s Department of Pharmacy, comprised of 240 full time employee positions. Residents study and practice under the supervision of specialists in Drug Information, Medication Safety, Quality Improvement, Informatics, and Investigational Drugs. The residency strengthens competencies in literature evaluation, clinical trial design, drug policy management, medication safety, adverse drug event analysis and direct patient care.
Development of critical thinking skills, project management, presentation preparation and delivery are important focuses of the training. The resident will complete formal residency projects at both GSK and Duke University Hospital and will present them at national scientific meetings. Residents also have opportunities to teach various allied health professionals including medical, nursing, and physical therapy students as well as to precept PharmD candidates on rotation.
For further information about the residency and application process please visit the Duke website.
- Drug Development Fellowship (PharmD or PhD)
- Clinical Pharmacokinetics/Pharmacodynamics Fellowship (PharmD or PhD)
The fellowship will begin July 1, 2013. Interested applicants should submit a letter of interest, curriculum vitae, unofficial transcript, and three letters of recommendation. Application materials must be sent electronically by January 1, 2013 to the following address:
Bob Dupuis, PharmD
Director of Clinical Fellowship Programs, DPET
Clinical Associate Professor
UNC Eshelman School of Pharmacy
- Drug/Medical Information Residency (PharmD)
The residency will begin July 1, 2014. Interested applicants should submit a letter of interest, curriculum vitae, and three letters of recommendation. Application materials must be sent electronically by January 1, 2014 to the following address:
Robert Morris, PharmD
Senior Medical Information Scientist